Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2-mutant Glioma.
Fanucci K, Pilat MJ, Shyr D, Shyr Y, Boerner S, Li J, Durecki D, Drappatz J, Puduvalli V, Lieberman FS, Gonzalez J, Giglio P, Ivy SP, Bindra RS, Omuro A, LoRusso P. Fanucci K, et al. Among authors: giglio p. Cancer Res Commun. 2023 Feb 2;3(2):192-201. doi: 10.1158/2767-9764.CRC-22-0436. eCollection 2023 Feb. Cancer Res Commun. 2023. PMID: 36968138 Free PMC article. Clinical Trial.
Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme.
Puduvalli VK, Giglio P, Groves MD, Hess KR, Gilbert MR, Mahankali S, Jackson EF, Levin VA, Conrad CA, Hsu SH, Colman H, de Groot JF, Ritterhouse MG, Ictech SE, Yung WK. Puduvalli VK, et al. Among authors: giglio p. Neuro Oncol. 2008 Apr;10(2):216-22. doi: 10.1215/15228517-2007-060. Epub 2008 Feb 26. Neuro Oncol. 2008. PMID: 18314417 Free PMC article. Clinical Trial.
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma.
Gilbert MR, Gonzalez J, Hunter K, Hess K, Giglio P, Chang E, Puduvalli V, Groves MD, Colman H, Conrad C, Levin V, Woo S, Mahajan A, de Groot J, Yung WK. Gilbert MR, et al. Among authors: giglio p. Neuro Oncol. 2010 Nov;12(11):1167-72. doi: 10.1093/neuonc/noq100. Epub 2010 Aug 20. Neuro Oncol. 2010. PMID: 20729242 Free PMC article. Clinical Trial.
Newly diagnosed high-grade gliomas.
Giglio P, Villano JL. Giglio P, et al. Curr Treat Options Neurol. 2010 Jul;12(4):309-20. doi: 10.1007/s11940-010-0077-6. Curr Treat Options Neurol. 2010. PMID: 20842590
Dural MALT lymphoma with disseminated disease.
Matmati K, Matmati N, Hannun YA, Rumboldt Z, Patel S, Lazarchick J, Stuart R, Giglio P. Matmati K, et al. Among authors: giglio p. Hematol Rep. 2010 Jan 26;2(1):e10. doi: 10.4081/hr.2010.e10. Epub 2010 Dec 3. Hematol Rep. 2010. PMID: 22184513 Free PMC article.
Drug resistance in glioblastoma: a mini review.
Haar CP, Hebbar P, Wallace GC 4th, Das A, Vandergrift WA 3rd, Smith JA, Giglio P, Patel SJ, Ray SK, Banik NL. Haar CP, et al. Among authors: giglio p. Neurochem Res. 2012 Jun;37(6):1192-200. doi: 10.1007/s11064-011-0701-1. Epub 2012 Jan 10. Neurochem Res. 2012. PMID: 22228201 Free PMC article. Review.
162 results